The Medicines Company Archives - Cardiovascular News

ACC 2017: Positive final results from ORION-1 phase II study of inclisiran

21st March 2017

The Medicines Company and...

The Medicines Company announces positive 180-day results for PCSK9 inhibitor

9th January 2017

The Medicines Company has...

AHA 2016: The Medicines Company and Alnylam Pharmaceuticals present positive results from ORION-1 phase 2 study of their PCSK9 inhibitor inclisiran

16th November 2016

The Medicines Company and...

Positive top-line results for The Medicines Company’s PCSK9si

19th October 2016

Data from the interim ana...

Data for The Medicines Company’s PCSK9si will be presented at AHA

6th October 2016

Interim analysis results ...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy